tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market

Senti Biosciences (SNTI) Income Statement

Compare
135 Followers

Senti Biosciences Income Statement

Last quarter (Q3 2024), Senti Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Senti Biosciences's net income was $-28.87M. See Senti Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.56M$ 4.29M$ 2.29M$ 394.00K$ 85.00K
Gross Profit
$ -2.68M$ 366.00K$ -719.00K$ -15.56M$ -14.44M
Operating Expenses
$ 95.29M$ 74.92M$ 42.74M$ 25.09M$ 7.39M
Depreciation and Amortization
$ 5.43M$ 3.89M$ 3.01M$ 1.99M$ 427.00K
EBITDA
$ -61.34M$ -70.63M$ -39.68M$ -22.71M$ -21.36M
Operating Income
$ -92.73M$ -70.63M$ -40.45M$ -24.69M$ -21.78M
Other Income/Expenses
$ 9.32M$ 12.42M$ -14.87M$ 4.83M$ 625.00K
Pretax Income
$ -83.41M$ -58.21M$ -55.32M$ -19.86M$ -21.16M
Net Income
$ -92.92M$ -58.21M$ -55.32M$ -19.86M$ -21.16M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -16.01$ -22.29$ -12.67$ -4.55$ -1.56
Diluted EPS
$ -16.01$ -22.29$ -12.67$ -4.55$ -1.56
Weighted Average Shares Outstanding
4.44M 2.61M 4.37M 4.37M 13.59M
Weighted Average Shares Outstanding (Diluted)
4.44M 2.61M 4.37M 4.37M 13.59M
Currency in USD

Senti Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis